Anthony Page - Captivision Ordinary Chief Officer
CAPT Stock | 1.36 0.01 0.74% |
Executive
Anthony Page is Chief Officer of Captivision Ordinary Shares
Age | 61 |
Address | 298-42 Cheongbukjungang-ro Cheongbuk-eup, Pyeongtaek-Si, South Korea |
Phone | 82 70 4896 4973 |
Web | https://www.captivision.com |
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Gerald Cummins | PennantPark Floating Rate | 70 | |
MSc MD | Apogee Therapeutics, Common | N/A | |
Brad Cochran | Cardinal Health | N/A | |
Ryan Crowe | Regeneron Pharmaceuticals | N/A | |
Ned MD | Regeneron Pharmaceuticals | N/A | |
Michael Karicher | Sonida Senior Living | 56 | |
Maya JD | Regeneron Pharmaceuticals | N/A | |
Mehrak Kiankarimi | Apogee Therapeutics, Common | N/A | |
Gerald Underwood | Regeneron Pharmaceuticals | N/A | |
Craig Cowman | Cardinal Health | N/A | |
Bob McCowan | Regeneron Pharmaceuticals | N/A | |
Scott McCabe | PennantPark Floating Rate | N/A | |
Monica Forbes | Apogee Therapeutics, Common | 49 | |
Andrew Murphy | Regeneron Pharmaceuticals | 67 | |
Matthew JD | Apogee Therapeutics, Common | 49 | |
Drew Badger | Apogee Therapeutics, Common | N/A | |
Mary Scherer | Cardinal Health | N/A | |
Maribeth Neelis | Sonida Senior Living | N/A | |
Matthew Visgilio | PennantPark Floating Rate | N/A | |
Rajesh Ahuja | Regeneron Pharmaceuticals | N/A | |
Christina Chan | Regeneron Pharmaceuticals | N/A |
Captivision Ordinary Leadership Team
Elected by the shareholders, the Captivision Ordinary's board of directors comprises two types of representatives: Captivision Ordinary inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Captivision. The board's role is to monitor Captivision Ordinary's management team and ensure that shareholders' interests are well served. Captivision Ordinary's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Captivision Ordinary's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anthony Page, Chief Officer | ||
Ryan Littman, Chief Officer | ||
Orhan Ertughrul, Managing Director | ||
Anthony CFA, Chief Officer | ||
Ho Lee, Chief Director | ||
Gary Garrabrant, CEO Chairman | ||
Alexander Marcinkowski, Senior Markets |
Captivision Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Captivision Ordinary a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Operating Margin | (0.48) % | ||||
Current Valuation | 67.19 M | ||||
Shares Outstanding | 32.67 M | ||||
Shares Owned By Insiders | 24.80 % | ||||
Shares Owned By Institutions | 2.73 % | ||||
Number Of Shares Shorted | 207.25 K | ||||
Price To Sales | 2.54 X | ||||
Revenue | 14.64 M | ||||
Gross Profit | 4.33 M | ||||
EBITDA | (69.06 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Captivision Stock Analysis
When running Captivision Ordinary's price analysis, check to measure Captivision Ordinary's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Captivision Ordinary is operating at the current time. Most of Captivision Ordinary's value examination focuses on studying past and present price action to predict the probability of Captivision Ordinary's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Captivision Ordinary's price. Additionally, you may evaluate how the addition of Captivision Ordinary to your portfolios can decrease your overall portfolio volatility.